1,2,3,>=4 prior line of therapy, Pomalidomide+Dexamethasone (Pd), Phase 3, Relapsed Refractory Multiple Myeloma (RRMM), Daratumumab+Pomalidomide+Dexamethasone (DPd), Anti-CD38 MAb, Lenalidomide Exposed
### Instruction:
Identify the study with the following condition. 
### Input:
1,2,3,>=4 prior line of therapy, Pomalidomide+Dexamethasone (Pd), Phase 3, Relapsed Refractory Multiple Myeloma (RRMM), Daratumumab+Pomalidomide+Dexamethasone (DPd), Anti-CD38 MAb, Lenalidomide Exposed 
### Output:
Popular Name is APOLLO, Study ID is NCT03180736